Search research articles
Contact Us
Filters
Showing results (131-140 of 1,725) with videos related to
Page
of 173
Sort By:
Current Opinion in Rheumatology
|
March 24, 2011
Monitoring rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Arthritis Research & Therapy
|
February 24, 2009
Developments in the clinical understanding of rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Rheumatic Diseases Clinics of North America
|
July 7, 2019
Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?
Daniel Aletaha, Josef S Smolen
Archives of Neurology
|
August 20, 2003
Support of progress in clinical neurology by models of genetic regulation
Paul Smolen, John H Byrne
Clinical and Experimental Rheumatology
|
February 19, 2004
Early arthritis. Introduction
T Pincus, J S Smolen
Clinical and Experimental Rheumatology
|
February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease
D Aletaha, J S Smolen
Biochemical Pharmacology
|
February 15, 1980
Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes
J E Smolen, G Weissmann
Clinical and Experimental Rheumatology
|
October 20, 2012
Gout: thoughts about a treat-to-target programme
Juergen Braun, Josef S Smolen
Rheumatology (Oxford, England)
|
June 22, 2012
Rheumatoid arthritis: where are we now?
Josef Smolen, Edward C Keystone
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
December 16, 1998
Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being
D M Smolen, R Topp
Page
of 173
Search research articles
Search
Showing results (131-140 of 1,725) with videos related to
Sort By:
Page
of 173
Current Opinion in Rheumatology
|
March 24, 2011
Monitoring rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Arthritis Research & Therapy
|
February 24, 2009
Developments in the clinical understanding of rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Rheumatic Diseases Clinics of North America
|
July 7, 2019
Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?
Daniel Aletaha, Josef S Smolen
Archives of Neurology
|
August 20, 2003
Support of progress in clinical neurology by models of genetic regulation
Paul Smolen, John H Byrne
Clinical and Experimental Rheumatology
|
February 19, 2004
Early arthritis. Introduction
T Pincus, J S Smolen
Clinical and Experimental Rheumatology
|
February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease
D Aletaha, J S Smolen
Biochemical Pharmacology
|
February 15, 1980
Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes
J E Smolen, G Weissmann
Clinical and Experimental Rheumatology
|
October 20, 2012
Gout: thoughts about a treat-to-target programme
Juergen Braun, Josef S Smolen
Rheumatology (Oxford, England)
|
June 22, 2012
Rheumatoid arthritis: where are we now?
Josef Smolen, Edward C Keystone
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
December 16, 1998
Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being
D M Smolen, R Topp
Page
of 173